OTTAWA, Oct 2 (Reuters) - Canada said on Friday that AstraZeneca AZN.L is the first pharmaceutical company to submit its COVID-19 candidate vaccine for authorization, and that a rolling review would begin immediately in order to speed up the review process.
Canada's Health Minister Patty Hajdu signed an order in September that allows "companies to submit safety and efficacy data and information as they become available" and accelerate the process, a statement said.